Literature DB >> 10085205

Secondary Injury After Head Trauma: Subacute and Long-term Mechanisms.

.   

Abstract

Mechanisms of the secondary injuries associated with traumatic brain injury, and their long-term effects on behavior and on the possible development of neurodegenerative disease, represent major opportunities to understand the brain's efforts at self-repair. A multiplicity of endogenous factors and genetic predispositions interact to affect outcomes. More pragmatically, the elucidation of such mechanisms offer multiple opportunities to intervene therapeutically.

Entities:  

Year:  1998        PMID: 10085205

Source DB:  PubMed          Journal:  Semin Clin Neuropsychiatry        ISSN: 1084-3612


  18 in total

1.  Fluid-percussion-induced traumatic brain injury model in rats.

Authors:  Shruti V Kabadi; Genell D Hilton; Bogdan A Stoica; David N Zapple; Alan I Faden
Journal:  Nat Protoc       Date:  2010-08-19       Impact factor: 13.491

2.  The dopamine and cAMP regulated phosphoprotein, 32 kDa (DARPP-32) signaling pathway: a novel therapeutic target in traumatic brain injury.

Authors:  James W Bales; Hong Q Yan; Xiecheng Ma; Youming Li; Ranmal Samarasinghe; C Edward Dixon
Journal:  Exp Neurol       Date:  2011-03-01       Impact factor: 5.330

3.  Comparing Plasma Phospho Tau, Total Tau, and Phospho Tau-Total Tau Ratio as Acute and Chronic Traumatic Brain Injury Biomarkers.

Authors:  Richard Rubenstein; Binggong Chang; John K Yue; Allen Chiu; Ethan A Winkler; Ava M Puccio; Ramon Diaz-Arrastia; Esther L Yuh; Pratik Mukherjee; Alex B Valadka; Wayne A Gordon; David O Okonkwo; Peter Davies; Sanjeev Agarwal; Fan Lin; George Sarkis; Hamad Yadikar; Zhihui Yang; Geoffrey T Manley; Kevin K W Wang; Shelly R Cooper; Kristen Dams-O'Connor; Allison J Borrasso; Tomoo Inoue; Andrew I R Maas; David K Menon; David M Schnyer; Mary J Vassar
Journal:  JAMA Neurol       Date:  2017-09-01       Impact factor: 18.302

4.  Exosomal MicroRNAs in Military Personnel with Mild Traumatic Brain Injury: Preliminary Results from the Chronic Effects of Neurotrauma Consortium Biomarker Discovery Project.

Authors:  Christina Devoto; Chen Lai; Bao-Xi Qu; Vivian A Guedes; Jacqueline Leete; Elisabeth Wilde; William C Walker; Ramon Diaz-Arrastia; Kimbra Kenney; Jessica Gill
Journal:  J Neurotrauma       Date:  2020-07-02       Impact factor: 5.269

Review 5.  Animal models of head trauma.

Authors:  Ibolja Cernak
Journal:  NeuroRx       Date:  2005-07

6.  Regional calcineurin subunit B isoform expression in rat hippocampus following a traumatic brain injury.

Authors:  James W Bales; Xiecheng Ma; Hong Q Yan; Larry W Jenkins; C Edward Dixon
Journal:  Brain Res       Date:  2010-08-13       Impact factor: 3.252

Review 7.  Glycosylation and other PTMs alterations in neurodegenerative diseases: Current status and future role in neurotrauma.

Authors:  Hussein Abou-Abbass; Hadi Abou-El-Hassan; Hisham Bahmad; Kazem Zibara; Abir Zebian; Rabab Youssef; Joy Ismail; Rui Zhu; Shiyue Zhou; Xue Dong; Mayse Nasser; Marwan Bahmad; Hala Darwish; Yehia Mechref; Firas Kobeissy
Journal:  Electrophoresis       Date:  2016-04-04       Impact factor: 3.535

Review 8.  Persistent cognitive dysfunction after traumatic brain injury: A dopamine hypothesis.

Authors:  James W Bales; Amy K Wagner; Anthony E Kline; C Edward Dixon
Journal:  Neurosci Biobehav Rev       Date:  2009-04-01       Impact factor: 8.989

Review 9.  Polymorphisms in genes modulating the dopamine system: do they inf luence outcome and response to medication after traumatic brain injury?

Authors:  Thomas W McAllister
Journal:  J Head Trauma Rehabil       Date:  2009 Jan-Feb       Impact factor: 2.710

10.  Systemic Elevation of n-3 Polyunsaturated Fatty Acids (n-3-PUFA) Is Associated with Protection against Visual, Motor, and Emotional Deficits in Mice following Closed-Head Mild Traumatic Brain Injury.

Authors:  Koushik Mondal; Haruka Takahashi; Jerome Cole; Nobel A Del Mar; Chunyan Li; Daniel J Stephenson; Jeremy Allegood; L Ashley Cowart; Charles E Chalfant; Anton Reiner; Nawajes Mandal
Journal:  Mol Neurobiol       Date:  2021-08-08       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.